Gline Matthew sold ROIV
December 15, 2025 · Form 4 insider transaction
Gline Matthew sold 943,527 shares of Roivant Sciences Ltd. at $21.68 per share, a transaction worth $20.46M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
943,527
Price
$21.68
Total value
$20.46M
InsiderGline Matthew
RoleOfficer, Director
CompanyRoivant Sciences Ltd. (ROIV)
SecurityCommon Shares
Transaction codeS: Open-market sale
Transaction dateDecember 15, 2025
Filing dateDecember 17, 2025
Shares owned after18,616,406
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
All options exercised by the reporting person would have expired in March or April 2026 if not exercised. The transactions reported on this Form 4 represent the disposition of the entirety of the reporting person's stock options expiring in 2026. As of the date of this filing, the reporting person has disgorged to the Issuer the full amount of the disgorgable profits realized from the sale reported herein, as required by Section 16(b) of the Securities Exchange Act of 1934.